Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
06/16/1993 | EP0547029A1 Immunogen and its use for preparing antibodies to HbA1c |
06/16/1993 | EP0547026A1 Gene coding for human colony-stimulating factors |
06/16/1993 | EP0546833A2 Calcium-regulated promoter |
06/16/1993 | EP0546813A2 Proteins for inhibiting adhesion of platelets to collagen |
06/16/1993 | EP0546787A2 Expression of specific immunogens using viral antigens |
06/16/1993 | EP0546721A1 Treating lignocellulosic materials |
06/16/1993 | EP0546634A2 Tumor associated monoclonal antibody 88BV59 |
06/16/1993 | EP0546333A1 Cloned DNA having enhancer activity, recombinant vector comprising the same and process for producing gene product using the same |
06/16/1993 | EP0546213A1 Biologically active polypeptide and antibacterial agent |
06/16/1993 | EP0546126A1 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome |
06/16/1993 | EP0546125A1 Osteogenic factor |
06/16/1993 | EP0546124A1 Multidomain hematopoiesis stimulators |
06/16/1993 | EP0546118A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
06/16/1993 | EP0546110A1 New insulin-like growth factor binding protein igfbp-5 |
06/16/1993 | EP0546096A1 Macrophage activating factor from vitamin d binding protein |
06/16/1993 | EP0546081A1 New insulin-like growth factor binding protein (igfbp-4) |
06/16/1993 | EP0546077A1 Cd18 peptide medicaments for the treatment of disease |
06/16/1993 | EP0546076A1 Use of anti-ICAM antibodies in the manufacture of a medicament FOR TREATING ENDOTOXIN SHOCK |
06/16/1993 | EP0546074A1 Genetic material encoding igfbp-5 |
06/16/1993 | EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
06/16/1993 | EP0546053A1 Genetic material encoding igfbp-4 |
06/16/1993 | EP0538412A4 A cdna encoding the rat d 1? dopamine receptor linked to adenylyl cyclase activation and expression product |
06/16/1993 | EP0406259B1 Antibodies, process for producing them, clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours |
06/16/1993 | EP0192741B1 $i(BACILLUS THURINGIENSIS) CRYSTAL PROTEIN GENE TOXIN SEGMENT |
06/16/1993 | CN1073208A Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
06/16/1993 | CN1021257C Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
06/15/1993 | US5220006 Identification of a suppressor of atherogenic apolipoprotein |
06/15/1993 | US5219997 Monoclonal antibody which inhibits the adhesion functions of the β integrin, CR3 |
06/15/1993 | US5219996 Recombinant antibodies and methods for their production in which surface residues are altered to cysteine residues for attachment of effector or receptor molecules |
06/15/1993 | US5219993 Method of recovering purified epi protein from a solution especially a fermentation solution |
06/15/1993 | US5219990 Papillomavirus e2 trans-activation repressors |
06/15/1993 | US5219738 Animal cell transformant, method for obtaining the transformant and method for producing desired foreign gene product by using the transformant |
06/15/1993 | US5219732 Antibody-mediated cofactor-driven reactions |
06/15/1993 | US5219725 Monoclonal antibodies to feline-t-lymphotropic lentivirus |
06/15/1993 | US5219579 Culture product of tumor tissue cells; cancer diagnosis, screening |
06/15/1993 | CA1319120C Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
06/14/1993 | CA2083542A1 Tumor associated monoclonal antibody 88bv59 |
06/13/1993 | CA2085089A1 Immunological detection method |
06/12/1993 | CA2084180A1 Expression of specific immunogens using viral antigens |
06/11/1993 | CA2084834A1 Proteins for inhibiting adhesion of platelets to collagen |
06/10/1993 | WO1993011254A1 Protease-stable proteins |
06/10/1993 | WO1993011252A1 Cloning vectors for expressing pcr generated variable regions as complete heavy and/or light chain(s) |
06/10/1993 | WO1993011248A1 Production of proteins using 7b2 protein |
06/10/1993 | WO1993011247A1 Prohormone convertase transformed cells |
06/10/1993 | WO1993011244A1 Cyclic di-guanylate metabolic enzymes |
06/10/1993 | WO1993011241A1 Nucleotide sequences coding an endopolygalacturonase inhibitor |
06/10/1993 | WO1993011240A1 Method for refolding igf-i to active conformation |
06/10/1993 | WO1993011239A1 New thrombin-inhibiting proteins from terrestrial leeches |
06/10/1993 | WO1993011238A1 Humanized b-b10, an anti-il2 receptor antibody |
06/10/1993 | WO1993011237A1 Cdr grafted humanised chimeric t-cell antibodies |
06/10/1993 | WO1993011236A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
06/10/1993 | WO1993011235A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
06/10/1993 | WO1993011234A1 Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
06/10/1993 | WO1993011232A1 Ifn-gamma antagonist cytokine |
06/10/1993 | WO1993011231A1 Tools for the diagnosis and treatment of alzheimer's disease |
06/10/1993 | WO1993011229A1 Novel polypeptides for promoting cell attachment |
06/10/1993 | WO1993011223A1 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments |
06/10/1993 | WO1993011162A1 Bispecific antibody heterodimers |
06/10/1993 | WO1993011161A1 Multivalent antigen-binding proteins |
06/10/1993 | WO1993011158A2 Non-a, non-b peptides |
06/10/1993 | WO1993011157A1 MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX) |
06/10/1993 | WO1993011153A1 Peptides and antibodies for treatment of rheumatoid arthritis |
06/10/1993 | WO1993011147A1 Dna encoding a human 5-ht1e receptor and uses thereof |
06/10/1993 | WO1993010805A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
06/10/1993 | CA2125298A1 Tools for the diagnosis and treatment of alzheimer's disease |
06/10/1993 | CA2125045A1 Nucleotide sequences coding an endopolygalacturonase inhibitor |
06/10/1993 | CA2124957A1 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments |
06/10/1993 | CA2124948A1 Gamma ifn-antagonist cytokine |
06/10/1993 | CA2124338A1 Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
06/10/1993 | CA2124316A1 Protease-stable proteins |
06/10/1993 | CA2123894A1 Bispecific antibody heterodimers |
06/10/1993 | CA2123694A1 Peptides and antibodies for treatment of rheumatoid arthritis |
06/10/1993 | CA2123567A1 Production of proteins using 7b2 protein |
06/10/1993 | CA2121800A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
06/10/1993 | CA2121601A1 Novel thrombin-inhibitory proteins from terrestrial leeches |
06/10/1993 | CA2101162A1 Dna encoding a human 5-ht1e receptor and uses thereof |
06/10/1993 | CA2057288A1 Trophoblast interferon |
06/09/1993 | EP0545554A2 Antibodies specific for RAR-gamma or a specific isoform of RAR-gamma |
06/09/1993 | EP0545352A1 Pharmaceutical compositions containing Lactobacillus casei peptidoglycan |
06/09/1993 | EP0545343A1 Ligand-binding domains of fibroblast growth factor receptors and chimeric proteins containing these domains |
06/09/1993 | EP0544942A1 Novel tools for the diagnosis and treatment of Alzheimer disease |
06/09/1993 | EP0544838A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
06/09/1993 | EP0544832A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
06/09/1993 | EP0544815A1 Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates |
06/09/1993 | EP0544743A1 Lymphokine 154 |
06/09/1993 | EP0463070B1 A process for producing pentapeptides and intermediates for use in the synthesis |
06/09/1993 | EP0368920B1 Lectines fixing beta-d-galactoside |
06/09/1993 | EP0327648B1 Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient |
06/09/1993 | EP0134242B1 Protective peptide antigen |
06/08/1993 | US5218101 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor |
06/08/1993 | US5218100 Dna encoding for the precursor protein of apc polypeptide associated with alzheimer's disease |
06/08/1993 | US5217896 For diagnosis and treatment of humoral hypercalcemia |
06/08/1993 | US5217889 Randomly fragmenting DNA homologous to gene to be supressed, transferring fragments to expression vectors, introducing supressor library into living cells, isolating modified cells and obtaining supressor element from cells |
06/08/1993 | US5217872 Diagnosing Lymes disease |
06/08/1993 | US5217871 Monoclonal antibodies to leptosphaeria nodorum |
06/08/1993 | US5217868 Measurement of an enzyme marker as an aid to diagnosis of liver transplant rejection |
06/08/1993 | US5217867 Measuring genetic transcription induced by steroid hormone receptors bound to DNA segments for use in screening assays |
06/08/1993 | CA1318869C Method of removing n-terminal amino acid residues from eucaryotic polypeptide analogs and polypeptides produced thereby |
06/08/1993 | CA1318867C Plasmid expression vector for use in escherichia coli |
06/07/1993 | CA2057213A1 Trophoblast interferon |